
Pelthos Therapeutics Inc.
NYSE · Biological Products, (No Diagnostic Substances)
Company Overview
A concise company profile alongside the latest public filing activity.
Pelthos Therapeutics is a commercial-stage pharmaceutical company focused on developing and marketing treatments in dermatology, including products for conditions such as excessive sweating. The company is headquartered in Durham, North Carolina.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Greenleaf PeterDirector | Sell | $17K | 797at $21.17 | Oct 2, 2026 |
| Pauls MatthewDirector | Sell | $17K | 786at $21.00 | Oct 2, 2026 |
| Friedberg Ezra MDirector | Sell | $12K | 558at $20.72 | Oct 2, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable PTHS activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.